Amazon’s Quarterly Revenue Beats Out Walmart… And Palantir’s Next Move 02/06/25
CNBC's "Fast Money"
00:00
Future of Orpherglypron and Market Impact
This chapter discusses the anticipated global release timeline for Orpherglypron, highlighting its market access potential and revenue comparisons with existing treatments. Additionally, it delves into the financial outlook of a pharmaceutical company focusing on growth prospects in various therapeutic areas, emphasizing cautious optimism in investment strategies.
Transcript
Play full episode
